M. Heffernan

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

R. Bell, M. Kovacs, A. Lichtenstein, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

G. Hortobagyi, R. Theriault, J. Simeone, 2000, Cancer.

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.

G. Hortobagyi, R. Theriault, H. Wheeler, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.

G. Hortobagyi, R. Theriault, J. Simeone, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone.

R. Theriault, R. Navari, S. Madajewicz, 1994, Archives of internal medicine.

Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.

M. Kovacs, A. Lichtenstein, J. Simeone, 1996, The New England journal of medicine.

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.

G. Hortobagyi, R. Theriault, H. Wheeler, 1996, The New England journal of medicine.

A two-stage procedure for selecting the largest normal mean whose first stage selects a bounded random number of populations

T. Santner, Maika Heffernan, M. Heffernan, 1992 .